Table 1. Results after median follow-up of 9 months. Results in percentages are shown in parentheses.

	Pancreatic adenocarcinoma (out of 5 patients)	Gastric adenocarcinoma (out of 2 patients)	Overall (out of 7 patients)
Median follow-up (months)	9	10.5	9
Tumor marker reduction (no. of patients)	4 (80%)	1 (50%)	5 (71 %)
Stable disease on CT (no. of patients)	3 (60%)	2 (100%)	5 (71 %)
Metabolic regression PET-CT (no. of patients)	3 (60%)	0 (0%)	3 (43 %)
Weight gain (no. of patients)	4 (80%)	0 (0%)	4 (57 %)